CenterBook Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.09M Sell
3,349
-1,512
-31% -$886K 0.1% 273
2026
Q2
$2.57M Buy
+4,861
New +$2.24M 0.13% 184
2026
Q1
– Sell
-3,603
Closed -$2.02M – 722
2025
Q4
$2.02M Sell
3,603
-2,693
-43% -$1.53M 0.1% 265
2025
Q3
$3.24M Buy
+6,296
New +$2.75M 0.16% 184

Other funds holding MEDP

CenterBook Partners's MEDP Position: Q3 2026 in Review

CenterBook Partners reduced its Medpace (MEDP) stake by 31% in Q3 2026, selling an estimated $886K and leaving 3,349 shares worth $2.09M. The position accounts for 0.1% of the portfolio, ranked #273.

CenterBook Partners first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.24M in Q3 2025. 386 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • CenterBook Partners held 3,349 shares of Medpace worth $2.09M as of Q3 2026.
  • CenterBook Partners sold 1,512 Medpace shares in Q3 2026, an estimated $886K.
  • Medpace made up 0.1% of CenterBook Partners's portfolio in Q3 2026, its #273 holding.
  • CenterBook Partners first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • CenterBook Partners's Medpace position peaked at $3.24M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.